RefLab ApS

RefLab is a Danish biotech company located in Copenhagen founded in 1991 as a spin-off of Lundbeck and now a member of R-Biopharm group in Germany. RefLab has proven track record with several big pharma companies together with established scientific collaborations with national and international universities and hospitals. We offer clinical sample testing for chronic spontanous urticaria and preclinical contract research within PK/PD, translational studies assessing potential hypersensitivity and toxicological effects as well as drug metabolism studies in a human ex vivo immune model. RefLab has a pre-existing ethical clearance, no time delays for project start-up. Applications for RefLab human...

Toxicology,drug metabolism,chronic spontaneous urticaria,drug allergy testing,allergy testing,preclinical contract research,pk/pd,food allergy testing,histamine detection,microdialysis,contract research,hypersensitivity reactions,human ex vivo skin models ,and preclinical immune models

Reflab aps operates in the Biotechnology research industry.

Reflab aps's revenue is 11m - 100m

Reflab aps has 11 - 50 employees.